Burden of Pulmonary Hypertension in Transcatheter Aortic Valve Implantation
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Cardiovascular revascularization medicine : including molecular interventions - 29(2021) vom: 15. Aug., Seite 93-94 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mujeeb, Firzah A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.10.2021 Date Revised 22.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.carrev.2020.08.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313885591 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313885591 | ||
| 003 | DE-627 | ||
| 005 | 20231225151535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.carrev.2020.08.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM313885591 | ||
| 035 | |a (NLM)32814674 | ||
| 035 | |a (PII)S1553-8389(20)30475-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mujeeb, Firzah A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Burden of Pulmonary Hypertension in Transcatheter Aortic Valve Implantation |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.10.2021 | ||
| 500 | |a Date Revised 22.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Mostafa, Mostafa R |e verfasserin |4 aut | |
| 700 | 1 | |a Alqahtani, Fahad |e verfasserin |4 aut | |
| 700 | 1 | |a Trabulsi, Almoutassim M |e verfasserin |4 aut | |
| 700 | 1 | |a Chundrigar, Mohsin |e verfasserin |4 aut | |
| 700 | 1 | |a Rawasia, Wasiq F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular revascularization medicine : including molecular interventions |d 2005 |g 29(2021) vom: 15. Aug., Seite 93-94 |w (DE-627)NLM158711297 |x 1878-0938 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2021 |g day:15 |g month:08 |g pages:93-94 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.carrev.2020.08.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2021 |b 15 |c 08 |h 93-94 | ||